Inform, educate, cure It's time to take patient participation in drug research seriously

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:5 / 5
页数:1
相关论文
共 50 条
  • [42] Ten-Year Experience for the Center for Drug Evaluation and Research, Part 2: FDA’s Role in Ensuring Patient Safety
    Jonathan P. Jarow
    Steven Lemery
    Kevin Bugin
    Naomi Lowy
    Therapeutic Innovation & Regulatory Science, 2017, 51 : 246 - 249
  • [43] Ten-Year Experience for the Center for Drug Evaluation and Research, Part 2: FDA's Role in Ensuring Patient Safety
    Jarow, Jonathan P.
    Lemery, Steven
    Bugin, Kevin
    Lowy, Naomi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (02) : 246 - 249
  • [45] DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM
    Peterziel, Heike
    Jamaladdin, Nora
    El Harouni, Dina
    Gerloff, Xenia F.
    Herter, Sonja
    Fiesel, Petra
    Berker, Yannick
    Blattner-Johnson, Mirjam
    Schramm, Kathrin
    Jones, Barbara C.
    Reuss, David
    Turunen, Laura
    Friedenauer, Aileen
    Holland-Letz, Tim
    Sill, Martin
    Weiser, Lena
    Previti, Christopher
    Ubramanian, Gnanaprakash Balas
    Gerber, Nicolas U.
    Gojo, Johannes
    Hutter, Caroline
    Ora, Ingrid
    Lohi, Olli
    Kattamis, Antonis
    De Wilde, Bram
    Termann, Frank Wes
    Tippelt, Stephan
    Graf, Norbert
    Nathrath, Michaela
    Sparber-Sauer, Monika
    Sehested, Astrid
    Kramm, Christof M.
    Dirksen, Uta
    Kallioniemi, Olli
    Pfister, Stefan M.
    Van Tilburg, Cornelis M.
    Jones, David T. W.
    Saarela, Jani
    Pietiainen, Vilja
    Jager, Natalie
    Schlesner, Matthias
    Kopp-Schneider, Annette
    Oppermann, Sina
    Milde, Till
    Witt, Olaf
    Oehme, Ina
    NEURO-ONCOLOGY, 2023, 25
  • [46] Time course, outcome and management of adverse drug reactions associated with metformin from patient’s perspective: a prospective, observational cohort study in the Netherlands
    Loek de Jong
    Linda Härmark
    Eugène van Puijenbroek
    European Journal of Clinical Pharmacology, 2016, 72 : 615 - 622
  • [47] Time course, outcome and management of adverse drug reactions associated with metformin from patient's perspective: a prospective, observational cohort study in the Netherlands
    de Jong, Loek
    Harmark, Linda
    van Puijenbroek, Eugene
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (05) : 615 - 622
  • [48] Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs), it's time to give more credits to patients' voice in research: the example of assessing hypoglycemia burden
    Wu, Zekai
    Bandini, Aude
    Brazeau, Anne-Sophie
    Rabasa-Lhoret, Remi
    DIABETES & METABOLISM, 2023, 49 (02)
  • [50] Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative
    Warner, John J.
    Crook, Hannah L.
    Whelan, Karley M.
    Bleser, William K.
    Roiland, Rachel A.
    Hamilton Lopez, Marianne
    Saunders, Robert S.
    Wang, Tracy Y.
    Hernandez, Adrian F.
    McClellan, Mark B.
    Califf, Robert M.
    Brown, Nancy
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (07): : 485 - 500